Chancellor Reeves Plans Focused Action on Bills in Upcoming Budget
Chancellor Reeves has stated she is preparing "focused action to deal with household expense pressures" in next month's Budget.
In comments to the BBC, she noted that reducing price rises is a joint duty of both the administration and the central bank.
The UK's price growth is forecast to be the highest among the G7 industrialized countries this year and the following year.
Potential Utility Bill Interventions
Reports indicate the government could intervene to bring down energy bills, such as by reducing the present 5% level of VAT applied on energy.
A further possibility is to lower some of the regulatory levies presently included in bills.
Budgetary Constraints and Analyst Predictions
The government will obtain the next assessment from the official forecaster, the OBR, on the start of the week, which will show how much room there is for such actions.
The expectation from the majority of analysts is that the Chancellor will have to declare tax rises or budget cuts in order to fulfill her declared fiscal targets.
Earlier on Thursday, estimates showed there was a £22 billion shortfall for the chancellor to address, which is at the more modest range of projections.
"It is a joint responsibility between the Bank of England and the government to continue tackling some of the sources of price increases," the Chancellor told the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.
Tax Commitments and International Concerns
While a great deal of the attention has been on probable tax increases, the chancellor said the latest information from the fiscal watchdog had not changed her commitment to campaign commitments not to raise rates on earnings tax, VAT or National Insurance.
She attributed an "unpredictable world" with rising geopolitical and trade concerns for the Budget revenue measures, likely to be directed on those "wealthiest."
International Trade Disputes
Commenting on worries about the United Kingdom's economic relations with the Asian nation she said: "The UK's security interests invariably are paramount."
Recent declaration by Chinese authorities to increase export controls on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader the US President to suggest an additional 100% tariff on imports from China, raising the risk of an all-out commercial conflict between the two global powers.
The American finance chief called the Chinese move "economic coercion" and "a global supply chain power grab."
Questioned on accepting the US offer to participate in its conflict with China, the Chancellor said she was "extremely troubled" by Chinese actions and encouraged the Beijing authorities "not to put up barriers and restrict access."
She said the move was "harmful for the global economy and creates further headwinds."
"It is my opinion there are fields where we should confront China, but there are also important chances to export to China's economy, including financial services and other sectors of the economic system. We've got to maintain that equilibrium appropriate."
The Treasury chief also stated she was cooperating with other major economies "regarding our own essential resources approach, so that we are less reliant."
NHS Medicine Pricing and Investment
Reeves also admitted that the cost the National Health Service spends on pharmaceuticals could rise as a consequence of ongoing negotiations with the US government and its drugs companies, in return for lower tariffs and investment.
A number of the world's largest drug companies have said in recent statements that they are either halting or canceling operations in the United Kingdom, with several blaming the low prices they are receiving.
Recently, the Science Minister said the cost the NHS pays for drugs would have to go up to prevent companies and drug research funding departing from the UK.
The Chancellor told the BBC: "It has been observed as a result of the pricing regime, that drug testing, recent pharmaceuticals have not been provided in the UK in the extent that they are in other continental states."
"Our aim is to ensure that people receiving care from the NHS are can obtain the top critical treatments in the world. And so we are examining all of that, and... seeking to attract more capital into the UK."